Human Anti-EPHA2 (clone 3F2) scFv-Fc Chimera (CAT#: VS-0325-FY81)

The anti-EPHA2 scFv-Fc antibody targets EPHA2, a receptor tyrosine kinase involved in angiogenesis, cell migration, and cancer progression. It can modulate EPHA2 signaling, potentially affecting vascular and tumor biology. The scFv-Fc format provides high specificity and prolonged half-life, enhancing its utility in research and therapeutic applications.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human EPHA2
  • Species Reactivity
  • Human
  • Clone
  • 3F2
  • Applications
  • ELISA, Immunofluorescence, Flow Cytometry
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Target

  • Alternative Names
  • EPH Receptor A2; Tyrosine-Protein Kinase Receptor ECK; EC 2.7.10.1; ECK; Epithelial Cell Receptor Protein Tyrosine Kinase; Ephrin Type-A Receptor 2; Soluble EPHA2 Variant 1; Epithelial Cell Kinase
  • Long Name
  • EPH Receptor A2
  • Sequence Similarities
  • Belongs to the ephrin receptor subfamily.
  • Cellular Localization
  • Cell membrane; Cell projection; ruffle membrane; Cell projection; lamellipodium membrane; Cell junction; focal adhesion
  • Post Translation Modifications
  • Autophosphorylates.
    Ubiquitinated by CHIP/STUB1.
    Glycosylation at Asn407 and Asn435
    Ubiquitination at Lys578
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyConnect EPHA2_HUMAN (777)
    Glycosylation from GlyGen 4 sites, 4 N-linked glycans (1 site), 2 O-linked glycans (2 sites)
  • Function
  • Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry.
    Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins.
    Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells.

Recommended Products

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 3F2"

See other products for "EPHA2"

Select a product category from the dropdown menu below to view related products.
Please select product type
ScFv Antibody Products Mouse Antibody Products Humanized Antibody Products MHC Tetramer Products for Cancer Rabbit Monoclonal Antibody Products Fab Antibody Products IgG Antibody Products Agonistic Antibody Products Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0325-FY81. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare